Geron Corporation (LON: 0IV3)
London
· Delayed Price · Currency is GBP · Price in USD
2.909
+0.020 (0.69%)
Jan 31, 2025, 6:25 PM BST
Geron Revenue
Geron had revenue of $28.27M USD in the quarter ending September 30, 2024, with 17,138.41% growth. This brings the company's revenue in the last twelve months to $29.48M, up 9,199.68% year-over-year. In the year 2023, Geron had annual revenue of $237.00K, down -60.23%.
Revenue (ttm)
$29.48M
Revenue Growth
+9,199.68%
P/S Ratio
n/a
Revenue / Employee
$209.08K
Employees
141
Market Cap
1.40B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 237.00K | -359.00K | -60.23% |
Dec 31, 2022 | 596.00K | -797.00K | -57.21% |
Dec 31, 2021 | 1.39M | 1.14M | 450.59% |
Dec 31, 2020 | 253.00K | -207.00K | -45.00% |
Dec 31, 2019 | 460.00K | -606.00K | -56.85% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
Hikma Pharmaceuticals | 2.39B |
ConvaTec Group | 1.74B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |
Geron News
- 11 days ago - Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 16 days ago - Geron: Positive IMpactMF Trial Could Possibly Lead To Doubling Of RYTELO Sales - Seeking Alpha
- 20 days ago - Geron updates on Q4 revenue from U.S. sales of RYTELO - Seeking Alpha
- 6 weeks ago - Geron Corp (GERN) Grants Stock Options to New Employees - GuruFocus
- 6 weeks ago - Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 7 weeks ago - Geron Corp (GERN) Receives Positive CHMP Opinion for RYTELO in Treating Blood Cancer - GuruFocus
- 7 weeks ago - Geron Announces Positive CHMP Opinion for RYTELO™ (imetelstat) for the Treatment of Adults with Transfusion-Dependent Anemia due to Lower-Risk MDS - Benzinga
- 7 weeks ago - Geron Announces Positive CHMP Opinion for RYTELO™ (imetelstat) for the Treatment of Adults with Transfusion-Dependent Anemia due to Lower-Risk MDS - Business Wire